Literature DB >> 26843640

Aβ-Induced Synaptic Alterations Require the E3 Ubiquitin Ligase Nedd4-1.

Elizabeth M Rodrigues1, Samantha L Scudder1, Marisa S Goo1, Gentry N Patrick2.   

Abstract

Alzheimer's disease (AD) is a neurodegenerative disease in which patients experience progressive cognitive decline. A wealth of evidence suggests that this cognitive impairment results from synaptic dysfunction in affected brain regions caused by cleavage of amyloid precursor protein into the pathogenic peptide amyloid-β (Aβ). Specifically, it has been shown that Aβ decreases surface AMPARs, dendritic spine density, and synaptic strength, and also alters synaptic plasticity. The precise molecular mechanisms by which this occurs remain unclear. Here we demonstrate a role for ubiquitination in Aβ-induced synaptic dysfunction in cultured rat neurons. We find that Aβ promotes the ubiquitination of AMPARs, as well as the redistribution and recruitment of Nedd4-1, a HECT E3 ubiquitin ligase we previously demonstrated to target AMPARs for ubiquitination and degradation. Strikingly, we show that Nedd4-1 is required for Aβ-induced reductions in surface AMPARs, synaptic strength, and dendritic spine density. Our findings, therefore, indicate an important role for Nedd4-1 and ubiquitin in the synaptic alterations induced by Aβ. SIGNIFICANCE STATEMENT: Synaptic changes in Alzheimer's disease (AD) include surface AMPAR loss, which can weaken synapses. In a cell culture model of AD, we found that AMPAR loss correlates with increased AMPAR ubiquitination. In addition, the ubiquitin ligase Nedd4-1, known to ubiquitinate AMPARs, is recruited to synapses in response to Aβ. Strikingly, reducing Nedd4-1 levels in this model prevented surface AMPAR loss and synaptic weakening. These findings suggest that, in AD, Nedd4-1 may ubiquitinate AMPARs to promote their internalization and weaken synaptic strength, similar to what occurs in Nedd4-1's established role in homeostatic synaptic scaling. This is the first demonstration of Aβ-mediated control of a ubiquitin ligase to regulate surface AMPAR expression.
Copyright © 2016 the authors 0270-6474/16/361590-06$15.00/0.

Entities:  

Keywords:  AMPA receptor; Nedd4-1; abeta; endocytosis; ubiquitin

Mesh:

Substances:

Year:  2016        PMID: 26843640      PMCID: PMC4737771          DOI: 10.1523/JNEUROSCI.2964-15.2016

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  22 in total

Review 1.  Alzheimer's disease is a synaptic failure.

Authors:  Dennis J Selkoe
Journal:  Science       Date:  2002-10-25       Impact factor: 47.728

2.  Beta-amyloid accumulation in APP mutant neurons reduces PSD-95 and GluR1 in synapses.

Authors:  Claudia G Almeida; Davide Tampellini; Reisuke H Takahashi; Paul Greengard; Michael T Lin; Eric M Snyder; Gunnar K Gouras
Journal:  Neurobiol Dis       Date:  2005-11       Impact factor: 5.996

3.  AMPA receptor downscaling at the onset of Alzheimer's disease pathology in double knockin mice.

Authors:  Eric H Chang; Mary J Savage; Dorothy G Flood; Justin M Thomas; Robert B Levy; Veeravan Mahadomrongkul; Tomoaki Shirao; Chiye Aoki; Patricio T Huerta
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-21       Impact factor: 11.205

Review 4.  The cell biology of synaptic plasticity: AMPA receptor trafficking.

Authors:  Jason D Shepherd; Richard L Huganir
Journal:  Annu Rev Cell Dev Biol       Date:  2007       Impact factor: 13.827

5.  AMPAR removal underlies Abeta-induced synaptic depression and dendritic spine loss.

Authors:  Helen Hsieh; Jannic Boehm; Chihiro Sato; Takeshi Iwatsubo; Taisuke Tomita; Sangram Sisodia; Roberto Malinow
Journal:  Neuron       Date:  2006-12-07       Impact factor: 17.173

6.  Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function.

Authors:  James P Cleary; Dominic M Walsh; Jacki J Hofmeister; Ganesh M Shankar; Michael A Kuskowski; Dennis J Selkoe; Karen H Ashe
Journal:  Nat Neurosci       Date:  2004-12-19       Impact factor: 24.884

7.  Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease.

Authors:  L F Lue; Y M Kuo; A E Roher; L Brachova; Y Shen; L Sue; T Beach; J H Kurth; R E Rydel; J Rogers
Journal:  Am J Pathol       Date:  1999-09       Impact factor: 4.307

8.  Regulation of NMDA receptor trafficking by amyloid-beta.

Authors:  Eric M Snyder; Yi Nong; Claudia G Almeida; Surojit Paul; Timothy Moran; Eun Young Choi; Angus C Nairn; Michael W Salter; Paul J Lombroso; Gunnar K Gouras; Paul Greengard
Journal:  Nat Neurosci       Date:  2005-07-17       Impact factor: 24.884

Review 9.  The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.

Authors:  John Hardy; Dennis J Selkoe
Journal:  Science       Date:  2002-07-19       Impact factor: 47.728

10.  Aggregation of secreted amyloid beta-protein into sodium dodecyl sulfate-stable oligomers in cell culture.

Authors:  M B Podlisny; B L Ostaszewski; S L Squazzo; E H Koo; R E Rydell; D B Teplow; D J Selkoe
Journal:  J Biol Chem       Date:  1995-04-21       Impact factor: 5.157

View more
  24 in total

1.  Tracking Effects of SIL1 Increase: Taking a Closer Look Beyond the Consequences of Elevated Expression Level.

Authors:  Thomas Labisch; Stephan Buchkremer; Vietxuan Phan; Laxmikanth Kollipara; Christian Gatz; Chris Lentz; Kay Nolte; Jörg Vervoorts; José Andrés González Coraspe; Albert Sickmann; Stephanie Carr; René P Zahedi; Joachim Weis; Andreas Roos
Journal:  Mol Neurobiol       Date:  2017-04-11       Impact factor: 5.590

Review 2.  Neuronal lysosomes.

Authors:  Shawn M Ferguson
Journal:  Neurosci Lett       Date:  2018-04-04       Impact factor: 3.046

3.  Ubiquitylation-dependent oligomerization regulates activity of Nedd4 ligases.

Authors:  Ilan Attali; William Sam Tobelaim; Avinash Persaud; Khatereh Motamedchaboki; Kobi J Simpson-Lavy; Bayan Mashahreh; Olga Levin-Kravets; Tal Keren-Kaplan; Inbar Pilzer; Martin Kupiec; Reuven Wiener; Dieter A Wolf; Daniela Rotin; Gali Prag
Journal:  EMBO J       Date:  2017-01-09       Impact factor: 11.598

Review 4.  Inhibiting BACE1 to reverse synaptic dysfunctions in Alzheimer's disease.

Authors:  Riqiang Yan; Qingyuan Fan; John Zhou; Robert Vassar
Journal:  Neurosci Biobehav Rev       Date:  2016-04-01       Impact factor: 8.989

5.  The WD40-Repeat Protein WDR-20 and the Deubiquitinating Enzyme USP-46 Promote Cell Surface Levels of Glutamate Receptors.

Authors:  Molly Hodul; Bethany J Rennich; Eric S Luth; Caroline L Dahlberg; Peter Juo
Journal:  J Neurosci       Date:  2021-02-23       Impact factor: 6.167

6.  Benzothiazole Amphiphiles Promote the Formation of Dendritic Spines in Primary Hippocampal Neurons.

Authors:  Jessica L Cifelli; Lara Dozier; Tim S Chung; Gentry N Patrick; Jerry Yang
Journal:  J Biol Chem       Date:  2016-03-28       Impact factor: 5.157

7.  Amyloid-β Induces AMPA Receptor Ubiquitination and Degradation in Primary Neurons and Human Brains of Alzheimer's Disease.

Authors:  Yanmin Zhang; Ouyang Guo; Yuda Huo; Guan Wang; Heng-Ye Man
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

Review 8.  HECT E3 ubiquitin ligases - emerging insights into their biological roles and disease relevance.

Authors:  Yaya Wang; Diana Argiles-Castillo; Emma I Kane; Anning Zhou; Donald E Spratt
Journal:  J Cell Sci       Date:  2020-04-07       Impact factor: 5.285

Review 9.  Illuminating Neural Circuits in Alzheimer's Disease.

Authors:  Yang Ying; Jian-Zhi Wang
Journal:  Neurosci Bull       Date:  2021-06-05       Impact factor: 5.271

Review 10.  Historical perspective and progress on protein ubiquitination at glutamatergic synapses.

Authors:  Angela M Mabb
Journal:  Neuropharmacology       Date:  2021-06-29       Impact factor: 5.273

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.